ALEMBIC PHARMACEUTICALS LTD. has reported financial results for the period ended December 31, 2020.
Financial Results (Q3 FY20-21) - QoQ Comparison
The company has reported total income of Rs.1316.86 crores during the period ended December 31, 2020 as compared to Rs.1460.32 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.292.57 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.333.37 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.14.88 for the period ended December 31, 2020 as compared to Rs.17.24 for the period ended September 30, 2020.
|
| Total Income | ₹ 1316.86 crs | ₹ 1460.32 crs |  -9.82% | | Net Profit | ₹ 292.57 crs | ₹ 333.37 crs | -12.24% | | EPS | ₹ 14.88 | ₹ 17.24 | -13.69% |
Financial Results (Q3 FY20-21) - YoY Comparison
The company has reported total income of Rs.1316.86 crores during the period ended December 31, 2020 as compared to Rs.1209.54 crores during the period ended December 31, 2019.
The company has posted net profit / (loss) of Rs.292.57 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.234.19 crores for the period ended December 31, 2019.
The company has reported EPS of Rs.14.88 for the period ended December 31, 2020 as compared to Rs.12.42 for the period ended December 31, 2019.
|
| Total Income | ₹ 1316.86 crs | ₹ 1209.54 crs |  8.87% | | Net Profit | ₹ 292.57 crs | ₹ 234.19 crs | 24.93% | | EPS | ₹ 14.88 | ₹ 12.42 | 19.81% |
Financial Results (9 Months ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.4118.81 crores during the 9 months period ended December 31, 2020 as compared to Rs.3402.97 crores during the 9 months period ended December 31, 2019.
The company has posted net profit / (loss) of Rs.927.41 crores for the 9 months period ended December 31, 2020 as against net profit / (loss) of Rs.604.18 crores for the 9 months period ended December 31, 2019.
The company has reported EPS of Rs.48.10 for the 9 months period ended December 31, 2020 as compared to Rs.32.05 for the 9 months period ended December 31, 2019.
|
| Total Income | ₹ 4118.81 crs | ₹ 3402.97 crs | 21.04% | | Net Profit | ₹ 927.41 crs | ₹ 604.18 crs | 53.5% | | EPS | ₹ 48.10 | ₹32.05 | 50.08% |
Mr. Pranav Amin, Managing Director, Alembic Pharmaceuticals Limited said "It was another good quarter for the company led by strong growth in the India formulation business. The API Business continued to perform well in current quarter."
Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.1070.1 as compared to the previous close of Rs. 1087.9. The total number of shares traded during the day was 11021 in over 799 trades.
The stock hit an intraday high of Rs. 1093.6 and intraday low of 1050.85. The net turnover during the day was Rs. 11743479. |
